Mutations in the gyrA and parC genes associated with fluoroquinolone resistance in clinical isolates of Citrobacter freundii

被引:12
作者
Nishino, Y [1 ]
Deguchi, T [1 ]
Yasuda, M [1 ]
Kawamura, T [1 ]
Nakano, M [1 ]
Kanematsu, E [1 ]
Ozeki, S [1 ]
Kawada, Y [1 ]
机构
[1] GIFU UNIV,SCH MED,DEPT UROL,GIFU 500,JAPAN
关键词
Citrobacter freundii; DNA gyrase; Topoisomerase IV;
D O I
10.1016/S0378-1097(97)00361-3
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
We determined partial sequences of the gyrA and parC genes of Citrobacter freundii type strain, and then examined 38 C. freundii clinical strains isolated from patients with urinary tract infections for the association of alterations in GyrA and ParC with susceptibility to fluoroquinolones. Our results suggest that in C. freundii DNA gyrase may be a primary target of quinolones, that an amino acid change at Thr-83 or Asp-87 in GyrA is sufficient to decrease susceptibility to fluoroquinolones, and that accumulation of changes in GyrA with the simultaneous presence of an alteration at Ser-80 or Glu-84 in ParC may be associated with the development of high-level fluoroquinolone resistance in C. freundii clinical isolates.
引用
收藏
页码:409 / 414
页数:6
相关论文
共 17 条
[1]   COMPARISON OF 2 MOLECULAR METHODS FOR TRACING NOSOCOMIAL TRANSMISSION OF ESCHERICHIA-COLI K1 IN A NEONATAL UNIT [J].
ALOS, JI ;
LAMBERT, T ;
COURVALIN, P .
JOURNAL OF CLINICAL MICROBIOLOGY, 1993, 31 (07) :1704-1709
[2]   NEISSERIA-GONORRHOEAE ACQUIRES MUTATIONS IN ANALOGOUS REGIONS OF GYRA AND PARC IN FLUOROQUINOLONE-RESISTANT ISOLATES [J].
BELLAND, RJ ;
MORRISON, SG ;
ISON, C ;
HUANG, WM .
MOLECULAR MICROBIOLOGY, 1994, 14 (02) :371-380
[3]   DNA GYRASE MUTATIONS IN QUINOLONE-RESISTANT CLINICAL ISOLATES OF NEISSERIA-GONORRHOEAE [J].
DEGUCHI, T ;
YASUDA, M ;
ASANO, M ;
TADA, K ;
IWATA, H ;
KOMEDA, H ;
EZAKI, T ;
SAITO, I ;
KAWADA, Y .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (02) :561-563
[4]   Quinolone-resistant Neisseria gonorrhoeae: Correlation of alterations in the GyrA subunit of DNA gyrase and the ParC subunit of topoisomerase IV with antimicrobial susceptibility profiles [J].
Deguchi, T ;
Yasuda, M ;
Nakano, M ;
Ozeki, S ;
Ezaki, T ;
Saito, I ;
Kawada, Y .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (04) :1020-1023
[5]   CLONING AND PRIMARY STRUCTURE OF STAPHYLOCOCCUS-AUREUS DNA TOPOISOMERASE-IV - A PRIMARY TARGET OF FLUOROQUINOLONES [J].
FERRERO, L ;
CAMERON, B ;
MANSE, B ;
LAGNEAUX, D ;
CROUZET, J ;
FAMECHON, A ;
BLANCHE, F .
MOLECULAR MICROBIOLOGY, 1994, 13 (04) :641-653
[6]   Ciprofloxacin-resistant Haemophilus influenzae strains possess mutations in analogous positions of GyrA and ParC [J].
Georgiou, M ;
Munoz, R ;
Roman, F ;
Canton, R ;
GomezLus, R ;
Campos, J ;
DelaCampa, AG .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (07) :1741-1744
[7]  
HIRAI K, 1990, 30 INT C ANT AG CHEM
[8]   NEW TOPOISOMERASE ESSENTIAL FOR CHROMOSOME SEGREGATION IN ESCHERICHIA-COLI [J].
KATO, J ;
NISHIMURA, Y ;
IMAMURA, R ;
NIKI, H ;
HIRAGA, S ;
SUZUKI, H .
CELL, 1990, 63 (02) :393-404
[9]   Quinolone-resistant mutants of Escherichia coli DNA topoisomerase IV parC gene [J].
Kumagai, Y ;
Kato, J ;
Hoshino, K ;
Akasaka, T ;
Sato, K ;
Ikeda, H .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (03) :710-714
[10]   OUTER-MEMBRANE PROTEINS RESPONSIBLE FOR MULTIPLE-DRUG RESISTANCE IN PSEUDOMONAS-AERUGINOSA [J].
MASUDA, N ;
SAKAGAWA, E ;
OHYA, S .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (03) :645-649